Tain You-Lin, Hsu Chien-Ning
Division of Pediatric Nephrology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.
Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.
Children (Basel). 2023 Jan 31;10(2):269. doi: 10.3390/children10020269.
Disruption of the composition and structure of the gut microbiota, namely dysbiosis, dictates the pathophysiology of kidney diseases. The bidirectional kidney-gut axis is of interest in chronic kidney disease (CKD); the uremic milieu leads to intestinal dysbiosis and gut microbial metabolites and toxins implicated in the loss of kidney function and increased comorbidity burden. Considering that kidney diseases can originate in childhood or even earlier in fetal life, identification of the pathogenetic connection between gut microbiota dysbiosis and the development of pediatric renal diseases deserves more attention. This review concentrates on the pathogenic link between dysbiotic gut microbiota and pediatric renal diseases, covering CKD, kidney transplantation, hemodialysis and peritoneal dialysis, and idiopathic nephrotic syndrome. Gut microbiota-targeted therapies including dietary intervention, probiotics, prebiotics, postbiotics and fecal microbial transplantation are discussed for their potential for the treatment of pediatric renal diseases. A deeper understanding of gut microbiota in pediatric renal diseases will aid in developing innovative gut microbiota-targeted interventions for preventing or attenuating the global burden of kidney diseases.
肠道微生物群的组成和结构破坏,即生态失调,决定了肾脏疾病的病理生理学。双向肾-肠轴在慢性肾脏病(CKD)中备受关注;尿毒症环境会导致肠道生态失调,而肠道微生物代谢产物和毒素与肾功能丧失及合并症负担增加有关。鉴于肾脏疾病可能始于儿童期甚至胎儿期更早阶段,确定肠道微生物群生态失调与小儿肾脏疾病发展之间的致病联系值得更多关注。本综述集中探讨了肠道微生物群生态失调与小儿肾脏疾病之间的致病联系,涵盖慢性肾脏病、肾移植、血液透析和腹膜透析以及特发性肾病综合征。讨论了针对肠道微生物群的治疗方法,包括饮食干预、益生菌、益生元、后生元及粪便微生物移植,探讨了它们在治疗小儿肾脏疾病方面的潜力。深入了解小儿肾脏疾病中的肠道微生物群将有助于开发创新的靶向肠道微生物群干预措施,以预防或减轻肾脏疾病的全球负担。